… in diabetes mellitus. The purpose of this study was to investigate if yoghurt enriched with
curcumin … , glycoxidative stress biomarkers, and paraoxonase 1 (PON 1) activity in diabetic rats. …

… to 2.2 g of Curcuma extract containing 180 mg of curcumin/day for 4 months) have been
documented… CUR analogs with improved antidiabetic activity for their potential therapeutic utility. …

… drugs to treat Type 2 diabetes mellitus seem to be of great utility. This approach seems likely
… new drugs for the management of Type 2 diabetes mellitus. Out of the two types of diabetes, …

… To chec the impact of Curcumin on glucose level, different diabetic rat models were utilized.
… and limited, reflecting a significant limitation of therapeutic utility. To determine the role of …

… clinical trials of curcumin in CVDs are overviewed and discussed. Finally, we discuss the
therapeutic utility of derivatives of curcumin, and highlight existing problems of curcumin as an …

… observed in turmeric and is made up of curcumin I (94%), curcumin II (6%), and curcumin
III (0.3%). Turmeric has also yielded demethoxy and bisdemethoxy compounds of curcumin. …

… Despite the existence of huge data about the hypoglycemic effect of curcumin (CUR) itself, …
diabetes mellitus using common chemical streptozotocin (STZ). STZ-induced diabetic rats …

… of antidiabetic drugs due to enhanced drug utility and decreased adverse effects. Surface …
transporter 2 in diabetes mellitus. The present research evaluated curcumin nanoparticles, …

… type 2 diabetes mellitus (T2DM). This study aimed to assess the effect of curcumin on glycemic
… Therefore, we performed this study to evaluate SNEC 30 Capsule utility in type 2 diabetes …

… Diabetes is predicted to affect 700 million people by the year 2045. Despite the potential
benefits for diabetics, curcumin’s low bioavailability significantly reduces its utility. However, …